Kunisada T, Yamada K, Oda S, Hara O
Pharmaceutical Research Center, Meiji Seika Kaisha Ltd., Yokohama, Japan.
Dermatology. 1997;195 Suppl 2:14-8. doi: 10.1159/000246025.
The bactericidal activity of commonly used antiseptics against clinical isolates was determined. It is noteworthy that povidone-iodine (PVP-I) solution showed high bactericidal activity against all of the test strains after 30 s of exposure. However, in the case of chlorhexidine gluconate (CHG), residual bacteria were observed in most species. Next, acquisition of resistance to antiseptics was examined, and it was found that remarkable increases in MICs were seen for CHG and alkyldiaminoethylglycine hydrochloride. The strains which acquired resistance against one antiseptic showed cross-resistance to all antiseptics except for PVP-I. As for bactericidal activity against biofilm, no viable cells were seen after a 10-min exposure to PVP-I solution. No decrease in viable cell count was seen even after a 60-min exposure to any of the other antiseptics. PVP-I showed high activities in all the tests conducted in this study. Thus, PVP-I was confirmed to be a clinically useful antiseptic.
测定了常用防腐剂对临床分离株的杀菌活性。值得注意的是,聚维酮碘(PVP-I)溶液在暴露30秒后对所有测试菌株均显示出高杀菌活性。然而,对于葡萄糖酸洗必泰(CHG),在大多数菌种中都观察到有残留细菌。接下来,检测了对防腐剂的耐药性获得情况,发现CHG和盐酸烷基二氨基乙基甘氨酸的最低抑菌浓度(MIC)显著增加。获得对一种防腐剂耐药性的菌株对除PVP-I之外的所有防腐剂均表现出交叉耐药性。至于对生物膜的杀菌活性,暴露于PVP-I溶液10分钟后未观察到活细胞。即使暴露于任何其他防腐剂60分钟后,活细胞计数也未见减少。在本研究进行的所有测试中,PVP-I均表现出高活性。因此,PVP-I被确认为一种临床有用的防腐剂。